Hospital Infection Therapeutic Market 2027 By Drug Type, Infections | The Insight Partners

Hospital Infection Therapeutic Market to 2027 - Global Analysis and Forecasts by Drug Type (Antibacterial Drugs, Antiviral Drugs, Antifungal Drugs); Infections (Hospital Acquired Pneumonia, Surgical Site Infections, Urinary Tract Infection, Gastrointestinal Disorders, Bloodstream Infections, Other Hospital Infections.)

Report Code: TIPRE00004596 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
MARKET INTRODUCTION
Hospital Infection Therapeutics are used for treating Hospital Acquired diseases which are nosocomial infections that could be acquired by the patient from another patient in the hospital, the surroundings and environment of the hospital or any other health care facility.

MARKET DYNAMICS
The Hospital Infection Therapeutic market is anticipated to grow in the forecast period owing to driving factors such as increasing number of hospital admitted patients, complacency among healthcare providers, growing antimicrobial resistance among certain strains of bacteria, poor infrastructure, understaffing and insufficient hospital equipment, overcrowding and lack of knowledge about blood transfusion safety measures and rising geriatric population. Nevertheless, strict regulatory requirement, high cost of treatment and lack of transparent reimbursement scenario is expected to hinder the market growth during the forecast period.

MARKET SCOPE
The "Global Hospital Infection Therapeutic Market Analysis to 2027" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of Hospital Infection Therapeutic market with detailed market segmentation by drug type, infections and geography. The global Hospital Infection Therapeutic market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Hospital Infection Therapeutic market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION
The global Hospital Infection Therapeutic market is segmented on the basis of Drug Type and Infections. Based on Drug Type the market is segmented into Antibacterial Drugs, Antiviral Drugs and Antifungal Drugs. Based on Infections the market is segmented into Hospital Acquired Pneumonia, Surgical Site Infections, Urinary Tract Infection, Gastrointestinal Disorders, Bloodstream Infections and Other Hospital Infections.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Hospital Infection Therapeutic market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Hospital Infection Therapeutic market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Hospital Infection Therapeutic market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Hospital Infection Therapeutic market in these regions.

MARKET PLAYERS
The reports cover key developments in the Hospital Infection Therapeutic Market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from Hospital Infection Therapeutic Market are anticipated to lucrative growth opportunities in the future with the rising demand for Hospital Infection Therapeutic in the global market. Below mentioned is the list of few companies engaged in the Hospital Infection Therapeutic market.

The report also includes the profiles of key Hospital Infection Therapeutic market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
  • Bayer Ag
  • Johnson & Johnson Services Inc.
  • Actavis Plc
  • Sanofi
  • Bristol Myers Squibb Company
  • AstraZeneca Plc
  • Pfizer Inc.
  • Merck & Co, Inc.
  • GlaxoSmithkline Plc
  • Cubist Pharmaceuticals, Inc.
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Hospital Infection Therapeutic Market - By Drug Type
1.3.2 Hospital Infection Therapeutic Market - By Infections
1.3.3 Hospital Infection Therapeutic Market - By Region
1.3.3.1 By Country
2. KEY TAKEWAYS
3. RESEARCH METHODOLOGY
4. HOSPITAL INFECTION THERAPEUTIC MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. HOSPITAL INFECTION THERAPEUTIC MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. HOSPITAL INFECTION THERAPEUTIC MARKET - GLOBAL MARKET ANALYSIS
6.1. HOSPITAL INFECTION THERAPEUTIC - GLOBAL MARKET OVERVIEW
6.2. HOSPITAL INFECTION THERAPEUTIC - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. HOSPITAL INFECTION THERAPEUTIC MARKET - REVENUE AND FORECASTS TO 2027 - DRUG TYPE
7.1. OVERVIEW
7.2. DRUG TYPE MARKET FORECASTS AND ANALYSIS
7.3. ANTIBACTERIAL DRUGS
7.3.1. Overview
7.3.2. Antibacterial Drugs Market Forecast and Analysis
7.4. ANTIVIRAL DRUGS
7.4.1. Overview
7.4.2. Antiviral Drugs Market Forecast and Analysis
7.5. ANTIFUNGAL DRUGS
7.5.1. Overview
7.5.2. Antifungal Drugs Market Forecast and Analysis
8. HOSPITAL INFECTION THERAPEUTIC MARKET - REVENUE AND FORECASTS TO 2027 - INFECTIONS
8.1. OVERVIEW
8.2. INFECTIONS MARKET FORECASTS AND ANALYSIS
8.3. HOSPITAL ACQUIRED PNEUMONIA
8.3.1. Overview
8.3.2. Hospital Acquired Pneumonia Market Forecast and Analysis
8.4. SURGICAL SITE INFECTIONS
8.4.1. Overview
8.4.2. Surgical Site Infections Market Forecast and Analysis
8.5. URINARY TRACT INFECTION
8.5.1. Overview
8.5.2. Urinary Tract Infection Market Forecast and Analysis
8.6. GASTROINTESTINAL DISORDERS
8.6.1. Overview
8.6.2. Gastrointestinal Disorders Market Forecast and Analysis
8.7. BLOODSTREAM INFECTIONS
8.7.1. Overview
8.7.2. Bloodstream Infections Market Forecast and Analysis
8.8. OTHER HOSPITAL INFECTIONS.
8.8.1. Overview
8.8.2. Other Hospital Infections. Market Forecast and Analysis
9. HOSPITAL INFECTION THERAPEUTIC MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Hospital Infection Therapeutic Market Overview
9.1.2 North America Hospital Infection Therapeutic Market Forecasts and Analysis
9.1.3 North America Hospital Infection Therapeutic Market Forecasts and Analysis - By Drug Type
9.1.4 North America Hospital Infection Therapeutic Market Forecasts and Analysis - By Infections
9.1.5 North America Hospital Infection Therapeutic Market Forecasts and Analysis - By Countries
9.1.5.1 United States Hospital Infection Therapeutic Market
9.1.5.1.1 United States Hospital Infection Therapeutic Market by Drug Type
9.1.5.1.2 United States Hospital Infection Therapeutic Market by Infections
9.1.5.2 Canada Hospital Infection Therapeutic Market
9.1.5.2.1 Canada Hospital Infection Therapeutic Market by Drug Type
9.1.5.2.2 Canada Hospital Infection Therapeutic Market by Infections
9.1.5.3 Mexico Hospital Infection Therapeutic Market
9.1.5.3.1 Mexico Hospital Infection Therapeutic Market by Drug Type
9.1.5.3.2 Mexico Hospital Infection Therapeutic Market by Infections
9.1.5.4 US Hospital Infection Therapeutic Market
9.1.5.4.1 US Hospital Infection Therapeutic Market by Drug Type
9.1.5.4.2 US Hospital Infection Therapeutic Market by Infections
9.2. EUROPE
9.2.1 Europe Hospital Infection Therapeutic Market Overview
9.2.2 Europe Hospital Infection Therapeutic Market Forecasts and Analysis
9.2.3 Europe Hospital Infection Therapeutic Market Forecasts and Analysis - By Drug Type
9.2.4 Europe Hospital Infection Therapeutic Market Forecasts and Analysis - By Infections
9.2.5 Europe Hospital Infection Therapeutic Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Hospital Infection Therapeutic Market
9.2.5.1.1 Germany Hospital Infection Therapeutic Market by Drug Type
9.2.5.1.2 Germany Hospital Infection Therapeutic Market by Infections
9.2.5.2 France Hospital Infection Therapeutic Market
9.2.5.2.1 France Hospital Infection Therapeutic Market by Drug Type
9.2.5.2.2 France Hospital Infection Therapeutic Market by Infections
9.2.5.3 Italy Hospital Infection Therapeutic Market
9.2.5.3.1 Italy Hospital Infection Therapeutic Market by Drug Type
9.2.5.3.2 Italy Hospital Infection Therapeutic Market by Infections
9.2.5.4 Spain Hospital Infection Therapeutic Market
9.2.5.4.1 Spain Hospital Infection Therapeutic Market by Drug Type
9.2.5.4.2 Spain Hospital Infection Therapeutic Market by Infections
9.2.5.5 United Kingdom Hospital Infection Therapeutic Market
9.2.5.5.1 United Kingdom Hospital Infection Therapeutic Market by Drug Type
9.2.5.5.2 United Kingdom Hospital Infection Therapeutic Market by Infections
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Hospital Infection Therapeutic Market Overview
9.3.2 Asia-Pacific Hospital Infection Therapeutic Market Forecasts and Analysis
9.3.3 Asia-Pacific Hospital Infection Therapeutic Market Forecasts and Analysis - By Drug Type
9.3.4 Asia-Pacific Hospital Infection Therapeutic Market Forecasts and Analysis - By Infections
9.3.5 Asia-Pacific Hospital Infection Therapeutic Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Hospital Infection Therapeutic Market
9.3.5.1.1 Australia Hospital Infection Therapeutic Market by Drug Type
9.3.5.1.2 Australia Hospital Infection Therapeutic Market by Infections
9.3.5.2 China Hospital Infection Therapeutic Market
9.3.5.2.1 China Hospital Infection Therapeutic Market by Drug Type
9.3.5.2.2 China Hospital Infection Therapeutic Market by Infections
9.3.5.3 India Hospital Infection Therapeutic Market
9.3.5.3.1 India Hospital Infection Therapeutic Market by Drug Type
9.3.5.3.2 India Hospital Infection Therapeutic Market by Infections
9.3.5.4 Japan Hospital Infection Therapeutic Market
9.3.5.4.1 Japan Hospital Infection Therapeutic Market by Drug Type
9.3.5.4.2 Japan Hospital Infection Therapeutic Market by Infections
9.3.5.5 South Korea Hospital Infection Therapeutic Market
9.3.5.5.1 South Korea Hospital Infection Therapeutic Market by Drug Type
9.3.5.5.2 South Korea Hospital Infection Therapeutic Market by Infections
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Hospital Infection Therapeutic Market Overview
9.4.2 Middle East and Africa Hospital Infection Therapeutic Market Forecasts and Analysis
9.4.3 Middle East and Africa Hospital Infection Therapeutic Market Forecasts and Analysis - By Drug Type
9.4.4 Middle East and Africa Hospital Infection Therapeutic Market Forecasts and Analysis - By Infections
9.4.5 Middle East and Africa Hospital Infection Therapeutic Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Hospital Infection Therapeutic Market
9.4.5.1.1 South Africa Hospital Infection Therapeutic Market by Drug Type
9.4.5.1.2 South Africa Hospital Infection Therapeutic Market by Infections
9.4.5.2 Saudi Arabia Hospital Infection Therapeutic Market
9.4.5.2.1 Saudi Arabia Hospital Infection Therapeutic Market by Drug Type
9.4.5.2.2 Saudi Arabia Hospital Infection Therapeutic Market by Infections
9.4.5.3 U.A.E Hospital Infection Therapeutic Market
9.4.5.3.1 U.A.E Hospital Infection Therapeutic Market by Drug Type
9.4.5.3.2 U.A.E Hospital Infection Therapeutic Market by Infections
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Hospital Infection Therapeutic Market Overview
9.5.2 South and Central America Hospital Infection Therapeutic Market Forecasts and Analysis
9.5.3 South and Central America Hospital Infection Therapeutic Market Forecasts and Analysis - By Drug Type
9.5.4 South and Central America Hospital Infection Therapeutic Market Forecasts and Analysis - By Infections
9.5.5 South and Central America Hospital Infection Therapeutic Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Hospital Infection Therapeutic Market
9.5.5.1.1 Brazil Hospital Infection Therapeutic Market by Drug Type
9.5.5.1.2 Brazil Hospital Infection Therapeutic Market by Infections
9.5.5.2 Argentina Hospital Infection Therapeutic Market
9.5.5.2.1 Argentina Hospital Infection Therapeutic Market by Drug Type
9.5.5.2.2 Argentina Hospital Infection Therapeutic Market by Infections
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. HOSPITAL INFECTION THERAPEUTIC MARKET, KEY COMPANY PROFILES
11.1. BAYER AG
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. JOHNSON & JOHNSON SERVICES INC
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. ACTAVIS PLC
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. SANOFI
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. BRISTOL MYERS SQUIBB COMPANY
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. ASTRAZENECA PLC
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. PFIZER INC
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. MERCK & CO, INC
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. GLAXOSMITHKLINE PLC
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. CUBIST PHARMACEUTICALS, INC.
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies

- Bayer Ag
- Johnson & Johnson Services Inc.
- Actavis Plc
- Sanofi
- Bristol Myers Squibb Company
- AstraZeneca Plc
- Pfizer Inc.
- Merck & Co, Inc.
- GlaxoSmithkline Plc
- Cubist Pharmaceuticals, Inc.